| |
| |
|
| Insider
Information: |
St Peter Steven |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
721,630 |
|
|
Indirect Shares
|
3,377,476 |
|
|
| Direct
Value |
$4,093,680 |
|
|
|
Indirect Value
|
$88,645,767 |
|
|
| Total
Shares |
4,099,106 |
|
|
| Total
Value |
$92,739,447 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pacira Pharmaceuticals, Inc. |
PCRX |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
3,290,479 |
Premium* |
|
|
Aratana Therapeutics, Inc. |
PETX |
PRESIDENT AND CEO, Dir... |
2018-12-17 |
516,626 |
2018-12-17 |
86,997 |
Premium* |
|
|
Altimmune, Inc |
ALT |
Director |
2017-01-04 |
205,004 |
2015-03-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2018-12-17 |
4 |
AS |
$5.85 |
$269,788 |
D/D |
(46,094) |
516,626 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2018-10-30 |
4 |
AS |
$5.86 |
$67,454 |
D/D |
(11,513) |
562,720 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2018-09-21 |
4 |
AS |
$6.06 |
$454,305 |
D/D |
(75,000) |
574,233 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2018-07-30 |
4 |
AS |
$4.33 |
$49,842 |
D/D |
(11,513) |
649,233 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2018-04-30 |
4 |
S |
$5.00 |
$57,582 |
D/D |
(11,513) |
660,746 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2018-04-30 |
4/A |
AS |
$5.00 |
$57,582 |
D/D |
(11,513) |
660,746 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2018-01-30 |
4 |
AS |
$4.77 |
$92,301 |
D/D |
(19,367) |
672,259 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2018-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
135,600 |
691,626 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2017-12-20 |
4 |
OE |
$3.14 |
$83,734 |
D/D |
26,667 |
556,026 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2017-11-10 |
4 |
AS |
$7.00 |
$350,000 |
D/D |
(50,000) |
529,359 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2017-10-02 |
4 |
AS |
$6.24 |
$312,115 |
D/D |
(50,000) |
579,359 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2017-04-17 |
4 |
OE |
$3.14 |
$146,531 |
D/D |
46,666 |
629,359 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2017-04-17 |
4 |
AS |
$5.54 |
$277,150 |
D/D |
(50,000) |
582,693 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2017-01-27 |
4 |
AS |
$7.72 |
$385,875 |
D/D |
(50,000) |
632,693 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2017-01-13 |
4 |
A |
$0.00 |
$0 |
D/D |
139,900 |
682,693 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2017-01-04 |
4 |
OE |
$2.20 |
$181,500 |
D/D |
70,000 |
205,004 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2016-12-15 |
4 |
AS |
$7.63 |
$381,380 |
D/D |
(50,000) |
542,793 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2016-12-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
50,000 |
592,793 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2016-09-16 |
4 |
OE |
$1.45 |
$175,907 |
D/D |
110,004 |
135,004 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2016-08-09 |
4 |
AS |
$9.25 |
$462,500 |
D/D |
(50,000) |
642,793 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2016-06-17 |
4 |
AS |
$6.32 |
$158,020 |
D/D |
(25,000) |
692,793 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2016-06-16 |
4 |
AS |
$6.24 |
$468,293 |
D/D |
(75,000) |
717,793 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2016-01-22 |
4 |
A |
$0.00 |
$0 |
D/D |
97,500 |
792,793 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2015-03-19 |
4 |
B |
$1.65 |
$41,213 |
D/D |
25,000 |
25,000 |
2.39 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
PRESIDENT AND CEO |
• • – |
2015-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
85,900 |
695,294 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
